Drug Trial Radar · NCT07808697
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Sep 4, 2026
Primary completion
Aug 30, 2029
Study completion Aug 30, 2029
Sponsor
- Lead sponsor
- ModernaTX, Inc.Moderna (MRNA)
- Sponsor type
- Industry
- First posted
- Sep 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 11 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.
Conditions
- SARS-CoV-2
Interventions
mRNA-1283Biological
Sterile liquid for injection
mRNA-1273Biological
Sterile liquid for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1 and Cohort 2: Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs)Time frame: Day 1 through Day 7; 7 Days following injection
- Cohort 1 and Cohort 2: Number of Participants with Unsolicited Adverse Events (AEs)Time frame: Day 1 through Day 28 (Cohort 1); 28 Days following injection (Cohort 2)
- Cohort 1 and Cohort 2: Number of Participants with Any Medically Attended AEs (MAAEs), Serious AEs (SAEs), AEs of Special Interest (AESIs), and AEs Leading to Discontinuation from the StudyTime frame: Day 1 through End of Study (Month 13)
- Cohort 1 and Cohort 2: Geometric Mean Value of Antibody Level Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Target VariantTime frame: Day 29 VISIT (Cohort 1), Day 57 VISIT (Cohort 2)
- Cohort 1 and Cohort 2: Geometric Mean Fold Rise of Antibody Level Against SARS-CoV-2Time frame: Day 29 (Cohort 1), Day 57 (Cohort 2)
- Cohort 1 and Cohort 2: Number of Participants with Seroresponse RateTime frame: Day 29 (Cohort 1), Day 57 (Cohort 2)
Locations
31 sites in 6 countries. Site status is shown where the registry gives one.
Orange County Research Center
Ontario, California · Recruiting
Hope Research Network
Miami, Florida · Recruiting
Spotlight Research Center - Internal Medicine
Miami, Florida · Recruiting
Indago Research and Health Cen
Miami Lakes, Florida · Recruiting
MplusM - D&H Tamarac Research Center
Tamarac, Florida · Recruiting
Eagle Clinical Research, LLC
Chicago, Illinois · Not yet recruiting
Great Lakes Research Institute -Southfield
Southfield, Michigan · Recruiting
Senders Pediatrics
South Euclid, Ohio · Not yet recruiting
REX Clinical Trials
Beaumont, Texas · Recruiting
PanAmerican Clinical Research, LLC.
Brownsville, Texas · Recruiting
South Ogden Family Medicine
South Ogden, Utah · Recruiting
Clinical Research Partners
Richmond, Virginia · Recruiting
Childrens Hospital Regional Medical Center
Seattle, Washington · Not yet recruiting
Fundacion Respirar - Consultorios Medicos Dra De Salvo
Ciudad Autonoma, Buenos Aires, Argentina · Not yet recruiting
Instituto Medico de la Fundacion Estudios Clinicos
Casilda, Santa Fe Province, Argentina · Not yet recruiting
Hospital del Nino Jesus
San Miguel de Tucumán, Tucumán Province, Argentina · Not yet recruiting
Medvacplus Srl Fundacion Clinica Cruz Jiminian
Cristo Rey, Distrito Nacional (Santo Domingo), Dominican Republic · Not yet recruiting
Instituto Dermatologico y Cirugia de Piel ''Dr. Huberto Bogaert Diaz'' (IDCP-DHBD)
Santo Domingo, Distrito Nacional (Santo Domingo), Dominican Republic · Not yet recruiting
Hospital General y de Especialidades Nuestra Señora de la Altagracia
Salvaleón de Higüey, La Altagracia Province, Dominican Republic · Not yet recruiting
Hospital Materno Infantil San Lorenzo De Los Mina
Santo Domingo, Nacional, Dominican Republic · Not yet recruiting
Centro de Investigacion Clínica y Medicina Traslacional (CIMeT)
Guadalajara, Jalisco, Mexico · Not yet recruiting
Hospital Infantil de México Federico Gómez - Pediatric Gastroenterology
Mexico City, Mexico City, Mexico · Not yet recruiting
Instituto Nacional de Pediatria
Mexico City, Mexico City, Mexico · Not yet recruiting
PanAmerican Clinical Research - Queretaro
Querétaro City, Querétaro, Mexico · Not yet recruiting
Centro de Salud Tizimin
Tizimín, Yucatán, Mexico · Not yet recruiting
CEVAXIN Avenida Mexico
Caledonia, Panama · Not yet recruiting
CEVAXIN Chorrera
La Chorrera, Panama · Not yet recruiting
CEVAXIN 24 de Diciembre
Panama City, Panama · Not yet recruiting
Instituto de Investigaciones Cienti-ficas Y Servicios de Alta Tecnologia Asociacion de Interes Panama; . Centro de Investigación, Innovación y Gestión del Conocimiento de Ciudad de la Salud, Caja de Seguro social
Panama City, Panama · Not yet recruiting
Ponce Health Sciences University
Ponce, Puerto Rico · Recruiting
BRCR Global
San Juan, Puerto Rico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.